Ko Kudo

Title: The Innovative Contributions of Ko Kudo

Introduction

Ko Kudo is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of immune therapy through his innovative work on chimeric receptors. His research focuses on enhancing antibody-dependent cell-mediated cytotoxicity and improving antibody-based immunotherapy, particularly in cancer treatment.

Latest Patents

Ko Kudo holds a patent for "Chimeric receptors and uses thereof in immune therapy." This patent discloses chimeric receptors that comprise an extracellular domain with affinity for the Fc portion of an immunoglobulin molecule. The invention includes a transmembrane domain, at least one co-stimulatory signaling domain, and a cytoplasmic signaling domain featuring an immunoreceptor tyrosine-based activation motif. Additionally, the patent provides nucleic acids encoding these chimeric receptors and immune cells expressing them.

Career Highlights

Throughout his career, Ko Kudo has worked with prestigious institutions, including the National University of Singapore and St. Jude Children's Research Hospital. His work has significantly advanced the understanding and application of immune therapies.

Collaborations

Ko Kudo has collaborated with esteemed colleagues such as Dario Campana and Charles Wilson. Their combined expertise has contributed to the development of innovative therapeutic strategies in immunology.

Conclusion

Ko Kudo's contributions to the field of immune therapy through his patented inventions and collaborations highlight his role as a leading inventor in this critical area of research. His work continues to pave the way for advancements in cancer immunotherapy and related fields.